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Abstract: Chronic obstructive pulmonary disease (COPD) is associated with signiﬁ  cant 
morbidity and mortality. Its possible association with obstructive sleep apnea is a major cause 
of concern for clinicians. As the prevalence of both COPD and sleep apnea continues to rise, 
further investigation of this interaction is needed. In addition, COPD patients are at risk for 
hypoventilation during sleep due to the underlying respiratory dysfunction. In this study, 
13 COPD subjects and 13 non-COPD control subjects were compared for the presence and 
severity of obstructive sleep apnea and nocturnal hypoventilation. All 26 subjects had presented 
to a sleep clinic and showed no signs of daytime hypoxemia. After matching for BMI and 
age, COPD subjects had a similar prevalence of sleep apnea with a lower degree of severity 
compared to the control subjects. However, less severe events, such as RERA, occurred at 
similar rates between the two groups. There was no signiﬁ  cant difference between groups in 
the magnitude of oxyhemoglobin desaturation during sleep. Interestingly, severity and presence 
of nocturnal hypoxemia correlated with that of sleep apnea in the control group, but not in the 
COPD subjects. In conclusion, COPD without daytime hypoxemia was not a risk factor for 
sleep apnea or nocturnal hypoventilation in this study.
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Introduction
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality 
in many countries. It is currently the fourth leading cause of death in the United States 
and is expected to increase to the third leading cause by the year 2020 (Barnes 2000; 
Hurd 2000). Sleep related respiratory disturbances such as obstructive sleep apnea 
(OSA) may be present in such patients. As upper airway resistance has been shown to 
be increased in COPD patients during sleep when compared to wakefulness (Ballard 
1995), the overlapping with OSA is of clinical concern due to its high prevalence in 
the general population (24% of adult males and 9% of adult women) (Young et al 1993; 
Nieto et al 2000). There has been conﬂ  icting data in the literature regarding the preva-
lence of sleep disorder breathing in patients with COPD (Chaouat 1995; Guilleminault 
1980; Flenley 1985). A possible source of this controversy may relate to the technical 
difﬁ  culties involved in obtaining accurate data from monitoring sleep systems. One 
recent, large scale study evaluating data from the Sleep Heart Health Study (SHHS) 
found no association between mild obstructive airway disease and OSA (Sanders 
et al 2003). However, most of the data published in the literature was acquired using 
a thermistor or a thermocouple f or monitoring respiratory ﬂ  ow. Recent studies have 
demonstrated that these techniques may miss 25%–50% of respiratory events when 
compared to gold standard techniques, such as esophageal manometry (Norman 1997). 
Therefore, studies using less accurate respiratory monitoring techniques may miss or 
underreport respiratory events. Given the underlying pathophysiology of obstructive 
airway disease and the increased upper airway resistance seen during sleep, COPD International Journal of COPD 2007:2(4) 610
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patients are at risk for developing obstructive respiratory 
disturbance during sleep. Likewise, more subtle respiratory 
abnormalities, such as respiratory-effort related arousal 
(RERA) are associated with nocturnal cortical arousals 
and sleep fragmentation leading to subsequent daytime 
fatigue and somnolence. These events have not previously 
been evaluated in COPD patients. Because of the lack of 
an adequate non-invasive technique to monitor respiratory 
ﬂ  ow during sleep, the prevalence of respiratory disturbance 
associated with COPD is still uncertain.
Furthermore, COPD patients frequently complain of 
poor sleep quality and inadequate sleep (Calverley 1982; 
Cormick 1986). Some of the factors leading to sleep disrup-
tion in COPD patients may also be related to the worsening 
of respiratory function during sleep, which may result from 
nocturnal hypoventilation, ventilation-perfusion mismatch, 
and decreased functional residual capacity. Though decreases 
in nocturnal oxyhemoglobin saturation (SaO2) may occur 
during sleep in COPD patients, the episodes tend to be more 
pronounced during rapid eye movement (REM) stages of 
sleep due to loss of peripheral muscle tone and a functional 
dependence on an impaired ﬂ  attened diaphragm (Douglas 
1979; Stradling 1983; George 1987).
The nasal cannula/pressure transducer system has been 
considered the best non-invasive method to detect minimal 
changes in airflow during nocturnal polysomnogram 
(Ayappa 2000; Epstein et al 2000a, 2004; Montserrat et al 
1997; Thurnheer et al 2001) and has also been validated 
to detect RERA events (Ayappa 2000). In this study, we 
used the nasal cannula/pressure transducer system to evalu-
ate respiratory events and oxyhemoglobin desaturation in 
COPD patients without evidence of daytime hypoxemia 
referred for evaluation of sleep-disordered breathing. Our 
study compared a group of patients with COPD without 
daytime hypoxemia (PaO2  60 mmHg) to a non-COPD 
control group, matched for BMI and age, during an attended 
overnight sleep study.
Methods
Twenty-eight subjects were recruited during a one-year 
period from the Manhattan Veterans Administration Sleep 
Clinic. Participation in this study was offered to all subjects 
with a known history of COPD and absence of daytime 
hypoxemia who were referred to the clinic for evaluation of 
snoring. For each COPD subject, a control subject without 
COPD, matched for BMI and age was selected from the 
clinic pool of patients that were evaluated within the 6-week 
period that followed inclusion of each COPD subject. COPD 
was deﬁ  ned using the Global Initiative for Obstructive 
Lung Disease (GOLD) criteria (Pauwels et al 2001). All 
COPD patients had evidence of adequate oxygenation 
(PaO2  60 mmHg) during wakefulness. Exclusion criteria 
were: (1) current or past use of continuous positive airway 
pressure, bi-level or supplemental oxygen; (2) respiratory 
failure requiring hospitalization within the previous 8-weeks; 
and (3) diagnosis of anemia. For each control subject, 
pulmonary function test was performed to rule out obstruc-
tive airway pathology.
All patients underwent spirometry while in sitting 
position within 6-months of the study inclusion date. An 
arterial blood gas sampling was performed in all COPD 
subjects during wakefulness, at rest in sitting position to 
verify adequate oxygenation. The room air oxyhemoglobin 
saturation (RA) SaO2), FEV1 and FEV1/FVC were recorded 
during spirometry. Subsequently, all patients were admin-
istered the Epworth Sleepiness Scale (ESS) in order to 
assess daytime sleepiness (Johns 1991). Twenty six subjects 
(13 with COPD and 13 non-COPD controls) completed 
the sleep study. An attended nocturnal polysomnography 
was performed in all patients at their approximate routine 
sleeping hours. Recorded channels included electroenceph-
alogram (C3/A2, C4/A1, O1/A2, 02/A1), bilateral electro-
oculogram (EOG), submental and anterior tibialis 
electromyogram (EMG), EKG, rib cage and abdominal 
motion by inductive plethysmography, body position, 
nasal cannula/pressure transducer system for respiratory 
monitoring (Protech®, Woodenville, WA) and oximetry 
with digital signal extraction (Masimo®, Irvine, CA). This 
oximetry technology was chosen because it is based on real 
time acquisition and processing of SaO2 data and because it 
has improved detection in states of low perfusion, motion, 
and weak signal. Sleep data was recorded via Bio-logic® 
(Mundelein, IL). Standard Rechtschaffen and Kales 
criteria were used to score sleep; arousals and respiratory 
events were scored using the American Academy of Sleep 
Medicine criteria (1999). Respiratory events consisted of 
apneas, deﬁ  ned as a reduction in air ﬂ  ow = 90% associated 
with sustained chest and abdominal effort, hypopneas, 
deﬁ  ned as a reduction in air ﬂ  ow = 50% associated with 
sustained chest and abdominal effort, and RERA events, 
deﬁ  ned as inspiratory ﬂ  ow limitation events followed by an 
EEG arousal which was not associated with any other sleep 
disturbance. The apnea-hypopnea index (AHI) included 
obstructive apneas and hypopneas linked to oxyhemoglobin 
drop = 4%. The respiratory disturbance index (RDI) con-
sisted of the addition of the RERA hourly index to the AHI. International Journal of COPD 2007:2(4) 611
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All subjects signed an informed consent form and the study 
was approved by the IRB and GCRC.
Statistical analysis
All respiratory events were tabulated (apnea, hypopnea, 
and RERA) and calculated to a ﬁ  nal hourly index of events. 
Respiratory events were tabulated as both AHI and RDI. 
Other sleep variables included total sleep time (TST) and 
sleep efﬁ  ciency (SE). Decreases in oxyhemoglobin satura-
tion were tabulated as follows: (1) percentage of sleep time 
at SaO2  90% (TST%  90); (2) total sleep time (min) at 
SaO2  90% (TSTmin  90); and (3) lowest SaO2 level recorded 
during wake, and REM and non-REM stages of sleep.
The variables were examined for deviations from 
normality, and appropriate transformations were performed 
prior to analyses to satisfy model assumptions, whenever 
applicable. The sleep data were analyzed using SPSS® soft-
ware. Paired t-tests and Pearson’s correlation coefﬁ  cients 
were used for descriptive analyses. Conﬁ  dence intervals 
were calculated for each study variable for COPD and control 
subjects and for the pairwise differences between groups. 
Linear regression analysis was used to build prediction 
models and p-values of 0.05 (two-sided) were used for 
statistical signiﬁ  cance (with no adjustments for multiplicity).
Results
Twenty-eight subjects were recruited from the Manhattan 
Veterans Affairs Sleep Clinic to participate in this study. 
Two subjects who did not complete the overnight sleep study 
were excluded from analyses. A total of 13 subjects with a 
known history of COPD and absence of daytime hypoxemia 
and 13 control subjects without COPD were included in the 
analyses. All subjects were male.
Sleep apnea
Table 1 summarizes the study variables and the pairwise 
differences between COPD subjects and control subjects. 
Nocturnal attended polysomnography detected OSA as 
deﬁ  ned by AHI 5 events/hour in all subjects and controls. 
The AHI in COPD subjects was lower by an average of 13 
events/hour when compared to control subjects, despite 
their similar age and BMI (Figure 1). This difference was 
not statistically signiﬁ  cant. The mean AHI of the COPD 
subjects was 38.2 events/hour (95% CI: 23.7–54.5) vs 51.7 
events/hour (95% CI: 33.4–70.8) in the control subjects 
(p-value not signiﬁ  cant).
The RDI in COPD subjects was lower by an average 
of 13.5 events/hour as compared to control subjects during 
non-REM sleep and by an average of 6.3 events/hour as 
compared to control subjects during REM sleep. The mean 
non-REM RDI in COPD subjects was 40.2 events/hour (95% 
CI: 25.5–57.4) vs 53.6 events/hour (95% CI: 36.7–71.7) in 
control subjects. The mean REM RDI in COPD subjects was 
44.9 events/hour (95% CI: 32.5–58.4) vs 51.3 events/hour 
(95% CI: 35.8–65.9) in control subjects. However, these 
differences were not statistically signiﬁ  cant. In addition, 
Table 1 Baseline characteristics of all subjects by group
  Total      COPD        Non-COPD controls         
 N  Mean  SD  N  Mean  SD  N  Mean  SD
Age (yrs)  26  63.88  10.74  13  63.54  10.91  13  64.23  11.01
Body Mass Index (kg/m2)  26 31.31 5.03  13  30.85 5.32 13  31.77 4.88
TST  (min)  26  318.96 90.51  13 338.31 51.80 13  299.62 116.50
SE (%)  26  71.81  16.39  13  75.71  10.88  13  67.90  20.21
RDI (events/hour)  26  47.40  31.55  13  40.92  29.57  13  53.88  33.29
AHI (events/hour)  26  44.97  32.56  13  38.23  30.23  13  51.70  34.60
RERA (events/hour)  26  2.43  3.71  13  2.68  2.91  13  2.18  4.47
Non-REM RDI (events/hour)  26  46.88  32.30  13  40.16  30.64  13  53.60  33.71
REM RDI (events/hour)  24  48.09  26.36  12  44.92  24.18  12  51.27  29.08
Awake mean SaO2 (% Hgb)  26  94.03  2.30  13  94.09  2.03  13  93.97  2.63
Mean SaO2 during sleep (% Hgb)  26  93.19  2.57  13  93.35  1.98  13  93.03  3.12
TST at SaO2  90% (min)  26  33.38  52.79  13  28.42  23.67  13  38.33  72.05
Percentage of TST at SaO2  90% (% Hgb)  26  11.08  14.94  13  8.10  6.60  13  14.07  20.05
Lowest SaO2 during non-REM sleep (% Hgb)  26  77.27  9.21  13  79.62  8.19  13  74.92  9.89
Lowest SaO2 during REM sleep (% Hgb)  24  81.08  10.01  12  81.50  9.41  12  80.67  10.98
FEV1 (liters)  26  2.55  0.80  13  2.30  0.79  13  2.80  0.75
FVC (liters)  26  3.53  1.03  13  3.59  1.08  13  3.46  1.02
FEV1(% predicted)  26  75.77  20.1  13  66.77  18.27  13  84.77  18.33International Journal of COPD 2007:2(4) 612
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RERA events did not differ signiﬁ  cantly between the two 
groups. The mean RERA index in COPD subjects was 2.69 
events/hour (95% CI: 1.33–4.23) vs 2.18 events/hour (95% 
CI: 0.48–4.85) in control subjects.
Nocturnal hypoventilation
Hypoxemia during sleep, as deﬁ  ned by the percentage of 
sleep time spent at SaO2 levels below 90%, was similar 
between groups as seen in Figure 2. Additional measure-
ments of nocturnal hypoxemia and oxyhemoglobin satura-
tion during sleep and wakefulness were also not statistically 
signiﬁ  cant between groups, as shown in Figure 3.
The severity of sleep apnea as measured by AHI was 
a signiﬁ  cant predictor of the TST%  90 in the control 
group (r = 0.61, p  0.05). However, the association 
between TST%  90 and sleep apnea was not signiﬁ  cant 
in the COPD group (r = –0.15, p = ns). In the linear regres-
sion model, after controlling for BMI and FVC that could 
potentially confound the association of AHI and TST%  90, 
AHI was still a signiﬁ  cant predictor of TST%  90 in the 
control group. After backward elimination, AHI and COPD 
status were the only variables remaining in the model and 
this model was signiﬁ  cant (r = 0.66, p  0.05).
Other sleep variables
The mean sleep duration was increased in the COPD group 
by 38 minutes (95% CI for the difference: –100, 18.5), with 
a tendency towards a higher sleep efﬁ  ciency (by 8%, 95% 
CI: –21.9, 4.80), when compared to the control subjects. 
However, those differences were not statistically signiﬁ  cant. 
Sleep efﬁ  ciency was negatively associated with (RA) SaO2 
(r = –0.70, p = 0.01) in the control group. The arousal index, 
as measured by total number of EEG arousals divided by the 
TST in hours was similar between groups.
The assessment of daytime somnolence by the ESS 
demonstrated a tendency to slightly higher scores in control 
subjects when compared to COPD subjects (difference: 2.8 
points [–0.62, 6.38]). However, this difference was not statis-
tically signiﬁ  cant. Of note, the ESS score was not predictive 
of the severity of sleep apnea in either group. All subjects 
Figure 1 Boxplots of AHI, RDI, non-REM RDI and REM RDI in COPD subjects vs control subjects.
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had scores above 7 (range 7–23), which is lower than the 
cutoff commonly used for inclusion in sleep apnea research 
studies (ESS = 11).
Body mass index (BMI) was a signiﬁ  cant predictor of 
the severity of OSA in all subjects as shown in Figure 4 
(r = 0.60 and 0.75, for COPD and control patients respec-
tively, p  0.05).
There was no signiﬁ  cant association between BMI and 
lowest saturation in NREM sleep in either COPD patients 
or control subjects. The lowest saturation in REM sleep was 
negatively correlated with REM RDI in the control group 
(r = –0.67, p = 0.02). However, this association was not 
seen in the COPD subjects (r = –0.12), implying that other 
mechanisms controlling oxygen saturation levels may be 
present during REM sleep in COPD patients.
There was an inverse relationship in all subjects between 
severity of COPD by FEV/FVC ratio and BMI (r = –0.66, 
p  0.02), which was clinically conﬁ  rmed by ﬁ  ndings of 
muscle wasting in patients with more severe lung disease. 
Nonetheless, the severity of sleep apnea in COPD subjects 
was strongly associated with the severity of lung disease, 
measured by the FEV/FVC ratio (r = –0.85, p  0.001).
Discussion
The objective of this study was to compare the magnitude and 
speciﬁ  c features of OSA and nocturnal hypoventilation in an 
unselected sample of COPD patients without daytime hypox-
emia presenting to a sleep clinic for complaints of possible sleep 
apnea. A control group of age and BMI-matched subjects with-
out COPD was used for comparison. Our data demonstrated 
that COPD without daytime hypoxemia is not associated with 
increased severity of sleep apnea or nocturnal hypoxemia. In 
fact, most COPD subjects without daytime hypoxemia had 
similar to lower degrees of sleep apnea than control subjects 
without COPD. However, the patients with more severe COPD 
also had severe sleep apnea. The rate of less severe events, such 
as RERA was the same in both groups. This is concurrent to 
ﬁ  ndings described by other investigators using different respira-
tory monitoring techniques (Sanders et al 2003; Aoki 2005). 
In the present study, the mean AHI of COPD subjects was 
Figure 2 Boxplots of TST  90 (% and min) in COPD subjects vs control subjects.
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38.2 events/hour vs 51.7 events/hour in the control subjects. 
This result is similar to that published by Sanders et al who 
demonstrated a lower index of sleep apnea severity in COPD 
subjects that could not be explained by changes in BMI when 
compared to control subjects (Sanders et al 2003).
Interestingly, the effects of obesity on sleep apnea in 
COPD patients seem to be different than in control subjects. 
In fact, COPD patients may be protected against the effects 
of obesity on upper airway function, when compared to 
non-COPD patients. In this study, BMI was a much stronger 
predictor of sleep apnea severity in control subjects compared 
to COPD subjects. REM-related events and oxygen desatura-
tion during sleep were not dependent on AHI or obesity in 
COPD subjects. These ﬁ  ndings imply that other mechanisms 
may be the driving factors leading to respiratory disturbance 
and hypoxemia during sleep in COPD patients. These mecha-
nisms may correlate to changes in ventilation/perfusion and 
altered mechanisms of respiratory control, which are difﬁ  cult 
to document with standard clinical testing. As compared 
to control subjects, COPD subjects showed decreases in 
oxygen saturation during sleep that were independent of 
sleep apnea.
Subjects with COPD demonstrated adequate sleep dura-
tion and efﬁ  ciency. The levels of daytime sleepiness were 
similar in both groups, as all subjects tested positive for sleep 
apnea. Interestingly, the ESS score was not predictive of sleep 
apnea or lung disease severity, with all subjects scoring above 
7 on the scale. Some of the limitations of this study included 
the small sample size and the absence of females, which will 
limit our conclusions about COPD to subjects in settings that 
are similar to this VA-based sleep clinic population.
Conclusion
This study’s ﬁ  ndings demonstrate that mild COPD is not 
associated with increased severity of sleep apnea or nocturnal 
hypoxemia. Due to the fact that those factors in COPD do not 
appear to correlate with obesity, other mechanisms might be 
involved. The present ﬁ  ndings provide no basis for managing 
Figure 3 Boxplots of lowest SaO2 (Non-REM and REM).
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patients with COPD without daytime hypoxemia any differ-
ently than patients without lung disease in respect to sleep 
apnea evaluation.
COPD does not appear to be a risk factor that magniﬁ  es 
the severity of sleep apnea in COPD patients without daytime 
hypoxemia, regardless of the COPD severity. These ﬁ  ndings 
along with other published data in the literature set the stage 
for a more in depth future study of the incidence of OSA and 
other respiratory disturbances during sleep in COPD patients 
across the full spectrum of disease severity in patients with 
chronic lung disease.
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